Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123940) titled 'Efficacy and Safety of Gemcitabine-Cisplatin Plus Envafolimab as Neoadjuvan... Read More
Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123925) titled 'Efficacy and Safety of Immune Checkpoint Inhibitors in Combination With Eng... Read More
Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123928) titled 'A Prospective, Single-Arm Clinical Study of Ta-NPs Combined with Radiothera... Read More
Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123930) titled 'Safety and Tolerability of Au-TMP Nanoparticles in Combination With Radioth... Read More
Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123935) titled 'A Clinical Trial of Cationic Peptide-IL22BP mRNA for Safety, Tolerability, ... Read More
Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123941) titled 'Effects of Three Ventilation Modes on Respiratory Mechanics and Oxygenation... Read More
Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123926) titled 'A clinical trial to evaluate the safety, tolerability, and preliminary anti... Read More
Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123931) titled 'A Phase I Clinical Trial of YMN-A02 in Patients With Advanced pMMR Colorect... Read More
Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123936) titled 'A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Prelimin... Read More
Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123938) titled 'A Phase I, open-label, dose-escalation clinical study evaluating the safety... Read More